Filing Details

Accession Number:
0001209191-14-068898
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-11-14 17:14:18
Reporting Period:
2014-11-12
Filing Date:
2014-11-14
Accepted Time:
2014-11-14 17:14:18
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1009356 Salix Pharmaceuticals Ltd SLXP Pharmaceutical Preparations (2834) 943267443
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1314760 P William Forbes 8510 Colonnade Center Drive
Raleigh NC 27615
Evp Research&Devel & Cdo No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2014-11-12 11,200 $17.53 130,420 No 4 M Direct
Common Stock Acquisiton 2014-11-12 6,250 $17.63 136,670 No 4 M Direct
Common Stock Disposition 2014-11-12 11,079 $95.05 125,591 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Option to Buy Common Stock Disposition 2014-11-12 11,200 $0.00 11,200 $17.53
Common Stock Option to Buy Common Stock Disposition 2014-11-12 6,250 $0.00 6,250 $17.63
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2014-12-16 No 4 M Direct
0 2015-06-09 No 4 M Direct
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $94.62 to $95.45, inclusive. The reporting person undertakes to provide the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
  2. Options are 100% vested.